0001062993-21-006276.txt : 20210702
0001062993-21-006276.hdr.sgml : 20210702
20210702163554
ACCESSION NUMBER: 0001062993-21-006276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210702
DATE AS OF CHANGE: 20210702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACKEY CATHERINE J
CENTRAL INDEX KEY: 0001645330
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36596
FILM NUMBER: 211070723
MAIL ADDRESS:
STREET 1: 3595 JOHN HOPKINS COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trillium Therapeutics Inc.
CENTRAL INDEX KEY: 0001616212
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
BUSINESS PHONE: (416) 595-0627
MAIL ADDRESS:
STREET 1: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2021-07-01
0001616212
Trillium Therapeutics Inc.
TRIL
0001645330
MACKEY CATHERINE J
C/O TRILLIUM THERAPEUTICS INC.
2488 DUNWIN DRIVE
MISSISSAUGA
A6
L5L 1J9
ONTARIO, CANADA
1
0
0
0
Stock Option (Right to Buy)
9.70
2021-07-01
4
A
0
67000
0
A
2031-07-01
Common Shares
67000
67000
D
One-third of the options vest on the one year anniversary of the grant date and the remaining options vest in equal quarterly installments over the following two years.
/s/ James Parsons, Attorney-in-Fact
2021-07-02